Researchers warn: don't feed commercially sensitive data to cloud LLMs as labs eye drug discovery
SumitGup · x · 2026-09-09
A widely shared take argues that since OpenAI and Anthropic are moving into drug discovery, prompts disclosing scientifically or commercially valuable information (like drug targets) may be monitored and acted upon.
- Advice: never enter commercially sensitive data into an LLM you don't run locally — labs may be "idea farming"
- Anthropic's problem: it's increasingly seen as competing with its own customers, and pharma companies may stop disclosing drug-target IP to Claude
- Outside SF, many view OpenAI and Anthropic as interchangeable, so one company's behavior erodes trust in both
More from Companies & People
- WSJ: Anthropic researcher quits AI industry over fears of uncontrollable AGI race — peterwildeford · 2026-09-09
- Meta exec touts Muse as potentially the best new product of the year — alexandr_wang · 2026-09-09
- ZhenFund portfolio goes all-in on AI: hiring across models, robotics and chips — sujingshen · 2026-09-09
- Terence Tao slams OpenAI for scooping researchers' work, warns of lasting damage to math — Nikvest · 2026-09-09
- New AI podcast interviews attention paper author on its backstory — kchonyc · 2026-09-09
- Lenny shares: the scarce PM skill today is elevating other people's ambition — lennysan · 2026-09-09